Healthcare -
Biotechnology - NASDAQ - US
$ 1.82
-1.09 %
$ 382 M
Market Cap
-1.17
P/E
ALLO - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities ALLO - Allogene Therapeutics, Inc.
163 M
LAST VALUE
-0.11%
2 YEAR CAGR
17.69%
5 YEAR CAGR
0.00%
10 YEAR CAGR